Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05473182 · ClinicalTrials.gov registry record · NA
IndieTrainer: Enabling Individuals With Cerebral Palsy to Receive Power Mobility Training
A NA study, sponsored by Grand Valley State University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05473182 is a NA study that has completed, run by Grand Valley State University. The registered enrollment target is 25 participants.
The verdict
NCT05473182, a NA study, has completed, sponsored by Grand Valley State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Power wheelchairs offer children who are unable to independently opportunities for participation in social, educational, and leisure activities. Unfortunately, children who have severe cognitive, motor, or sensory impairments may need extended training to be able to master the power wheelchairs skills needed to "qualify" for their own power wheelchairs. The IndieTrainer system was developed to address this need. The IndieTrainer system is comprised of the IndieGo device and video-game modules. The IndieGo device temporarily converts a manual wheelchair into a powered wheelchair, thereby allowing children to remain in their own manual wheelchair and use their own custom seating system during power wheelchair skills training activities. The video-game modules are integrated into the IndieGo device such that the video games can be played on a television screen using the specific access method used to control the IndieGo (i.e., switch or joystick). The IndieTrainer system is designed to allow a child to practice power wheelchair skills as part of the video-game modules or as part of more traditional power wheelchair skills training activities wherein children are able to actively explore the environment and practice executing actual wheelchair skills. This study will evaluate the use of the IndieTrainer system in children with cerebral palsy, ages 3-21 years.
Interventions
- OTHER IndieTrainer system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-09-08 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05473182
The ClinicalTrials.gov registry entry for NCT05473182 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Grand Valley State University, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IndieTrainer system is the first listed.
NCT05473182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05473182 about?
NCT05473182 is a clinical study titled "IndieTrainer: Enabling Individuals With Cerebral Palsy to Receive Power Mobility Training". Power wheelchairs offer children who are unable to independently opportunities for participation in social, educational, and leisure activities. Unfortunately, children who have severe cognitive, motor, or sensory impairments may need extended training to be able to master the power wheelchairs skil...
What is the current status of trial NCT05473182?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-09-08. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT05473182?
The interventions under investigation include: IndieTrainer system (OTHER).
Who is sponsoring clinical trial NCT05473182?
This trial is sponsored by Grand Valley State University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.